NCT01046383View on ClinicalTrials.gov

Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients

PHASE3TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2013

Conditions
NON-SMALL CELL LUNG CANCER
Interventions
DIETARY_SUPPLEMENT

IMN1207

20 grams of IMN1207 per day for 40 weeks.

DIETARY_SUPPLEMENT

Casein

20 grams of Casein per day for 40 weeks

Trial Locations (5)

V5Z 1L3

British Columbia Cancer Agency, Vancouver

L8V 5C2

Juravinski Cancer Centre, Hamilton

H2L 4M1

CHUM - Hopital Notre Dame, Montreal

H3T 1E2

Jewish General Hospital, Montreal

S4T 7T1

Allan Blair Cancer Centre, Regina

Sponsors

Lead Sponsor

Immunotec Inc.
All Listed Sponsors
lead

Immunotec Inc.

INDUSTRY